CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (161)	12/31/1998 11:08:00 AM
From: Lighthouse	Read Replies (1) of 666

Hi Vector! I have continued to enjoy reading your posts and want to thank you for sharing your thoughts/insights/ideas with this discussion group throughout 1998. Happy New Year and Best Investing Wishes for 1999. It has been a few months since our last discussion of CLTR, IDPH and the overall market for NHL. Any new takes? The HAMA response rate for Bexxar was a bit higher than I had thought, but I liked the major-pharma deal they inked. Did the HAMA numbers surprise you? Last time around (Octoberish) IDPH looked slightly better in reagrds to the stock value vs CLTR, but that tradeoff vis-a-vis CLTR appears to have flipped. {In fact I have a very hard time understanding IDPH at the current $46 per share.} TIA P.S. For full and fair disclosure I am neither short nor long IDPH, CLTR.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next